ETFIQData as of Nov 18, 2026. · etfiq.com/funds/fny

FNY Fact Sheet: First Trust Mid Cap Growth AlphaDEX Fund

Share
$95.20
close, Nov 18, 2026

Over the year to Nov 18, 2026, FNY returned +9.7% in total and charged 0.73% a year.

1-year total return
+9.7%
IWV +12.0% to Nov 18, 2026
Expense ratio
0.73%
a year
Net assets
$529m
on Nov 17, 2026
Net flow, last 5 trading days
$0
daily basis to Nov 17, 2026

Growth of $10,000, 1 year

FNY $10,966 +9.7% · IWV $11,199 +12.0% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.

Returns

WindowTotal return
1 month−1.5%
3 months−9.9%
Year to date+4.4%
1 year+9.7%
3 years+58.2%
5 years+24.2%

Total return, distributions reinvested, each window to Nov 18, 2026.

Ten largest positions

HoldingWeight
Glaukos Corporation1.14%
Chime Financial, Inc. (Class A)0.96%
Concentra Group Holdings Parent, Inc.0.95%
Exelixis, Inc.0.91%
Hinge Health, Inc. (Class A)0.91%
LifeStance Health Group, Inc.0.91%
PACS Group, Inc.0.90%
Haemonetics Corporation0.89%
Charles River Laboratories International, Inc.0.87%
TG Therapeutics, Inc.0.87%

FNY top ten by weight, 9.3% of the fund, of its 225 equity positions, from the holdings published by its issuer for Nov 17, 2026.

Facts

Equity fund · Tracks the Nasdaq AlphaDEX Mid Cap Growth Index · First traded Apr 20, 2011 · Benchmark Russell 3000 Index, measured by IWV, which tracks the same index

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, FNY Fact Sheet: First Trust Mid Cap Growth AlphaDEX Fund. Data as of Nov 18, 2026. https://etfiq.com/funds/fny/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/fny.